A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining.
about
Tp53 and its potential therapeutic role as a target in bladder cancer.Molecular markers of DNA damage and repair in cervical cancer patients treated with cisplatin neoadjuvant chemotherapy: an exploratory study.Bone morphogenetic protein signaling is required for RAD51-mediated maintenance of genome integrity in vascular endothelial cells
P2860
A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A role for the p53 tumour supp ...... nd non-homologous end joining.
@en
A role for the p53 tumour supp ...... nd non-homologous end joining.
@nl
type
label
A role for the p53 tumour supp ...... nd non-homologous end joining.
@en
A role for the p53 tumour supp ...... nd non-homologous end joining.
@nl
prefLabel
A role for the p53 tumour supp ...... nd non-homologous end joining.
@en
A role for the p53 tumour supp ...... nd non-homologous end joining.
@nl
P2093
P2860
P356
P1433
P1476
A role for the p53 tumour supp ...... nd non-homologous end joining.
@en
P2093
Emma Christina Harte
Janna Luessing
Muriel Voisin
Sylvie Moureau
P2860
P356
10.1098/RSOB.160225
P577
2016-09-01T00:00:00Z